[ALNY] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
04-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- 0.71%
YoY- -31.62%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 21,033 2,069 29,907 21,899 37,924 17,096 15,932 20.28%
PBT -211,080 -244,837 -163,481 -141,276 -142,227 -122,937 -118,420 46.85%
Tax 361 445 79 -62 -7,949 -3,296 -2,577 -
NP -211,441 -245,282 -163,560 -141,214 -142,227 -122,937 -118,420 47.02%
Tax Rate - - - - - - - -
Total Cost 232,474 247,351 193,467 163,113 180,151 140,033 134,352 43.98%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin -1,005.28 -11,855.10 -546.90 -644.84 -375.03 -719.10 -743.28 22.23%
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -2.09 -2.43 -1.63 -1.41 -1.48 -1.34 -1.34 34.38%
EPS Diluted -2.09 -2.43 -1.63 -1.41 -1.48 -1.34 -1.34 34.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.